P

Inventor

KAMATA MAKOTO

JP40 patents
⚠️ This page may combine multiple inventors who share the name “KAMATA MAKOTO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAKEDA PHARMACEUTICALS CO

28 patents
US9518042B2Dec 13, 2016

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO8 citations92
US9499516B2Nov 22, 2016

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO8 citations92
US10548899B2Feb 4, 2020

Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity

TAKEDA PHARMACEUTICALS CO7 citations84
US10457670B2Oct 29, 2019

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease

TAKEDA PHARMACEUTICALS CO2 citations84
US10428056B2Oct 1, 2019

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO4 citations84
US10323027B2Jun 18, 2019

2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor

TAKEDA PHARMACEUTICALS CO4 citations84
US10087150B2Oct 2, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO5 citations84
US9878989B2Jan 30, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO7 citations84
US9868725B2Jan 16, 2018

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

TAKEDA PHARMACEUTICALS CO5 citations84
US9789083B2Oct 17, 2017

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations84
US9789084B2Oct 17, 2017

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations84
US9775827B2Oct 3, 2017

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations84
US9675597B2Jun 13, 2017

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations84
US9662316B2May 30, 2017

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations84
US9655881B2May 23, 2017

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO2 citations84
US10106556B2Oct 23, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO8 citations83
US10899752B2Jan 26, 2021

2,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor

TAKEDA PHARMACEUTICALS CO1 citations73
US10208046B2Feb 19, 2019

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO4 citations73
US9777005B2Oct 3, 2017

Bicyclic heterocyclic compound containing a substituted pyrrole ring

TAKEDA PHARMACEUTICALS CO5 citations73
US10807987B2Oct 20, 2020

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO5 citations72
US10865200B2Dec 15, 2020

Nitrogen-containing heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations63
US11827601B2Nov 28, 2023

Heterocyclic NMDA antagonists

TAKEDA PHARMACEUTICALS CO0 citations62
US11274101B2Mar 15, 2022

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO1 citations62
US11702419B2Jul 18, 2023

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO1 citations61
US11834409B2Dec 5, 2023

Heterocyclic NMDA antagonists

TAKEDA PHARMACEUTICALS CO0 citations60
US12590086B2Mar 31, 2026

3-((1H-pyrazol-4-yl)methyl)-6′-(phenyl)-2H-(1,2′-bipyridin)-2-one derivatives and related compounds as GPR139 antagonists for use in a method of treatment of e.g. depression

TAKEDA PHARMACEUTICALS CO0 citations50
US11952344B2Apr 9, 2024

Heterocyclic compound and use thereof

TAKEDA PHARMACEUTICALS CO0 citations50
US10131653B2Nov 20, 2018

Heterocyclic compound

TAKEDA PHARMACEUTICALS CO0 citations50

TAKEDA PHARMACEUTICAL

5 patents

TANIGUCHI TAKAHIKO

2 patents

KOIKE TATSUKI

2 patents

FUJITSU GENERAL LTD

1 patent

KAMATA MAKOTO

1 patent

YAMASHITA TOHRU

1 patent